INVST’s Bristol-Myers Squibb BMY Stock Holding History

INVST’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,680	Closed	-$248K	–	266
2024 Q1	$248K	Buy	4,680 +35	+0.8%	+$1.78K	0.03%	208
2023 Q4	$229K	Sell	4,645 -383	-8%	-$20.1K	0.03%	196
2023 Q3	$292K	Buy	5,028 +189	+4%	+$11.6K	0.04%	166
2023 Q2	$309K	Buy	4,839 +289	+6%	+$19.4K	0.04%	152
2023 Q1	$308K	Buy	4,550 +118	+3%	+$8.32K	0.05%	141
2022 Q4	$322K	Sell	4,432 -11	-0.2%	-$829	0.05%	134
2022 Q3	$304K	Sell	4,443 -155	-3%	-$11.2K	0.05%	139
2022 Q2	$344K	Sell	4,598 -23	-0.5%	-$1.75K	0.05%	140
2022 Q1	$352K	Buy	4,621 +541	+13%	+$36.3K	0.06%	139
2021 Q4	$277K	Sell	4,080 -9,833	-71%	-$577K	0.04%	153
2021 Q3	$823K	Sell	13,913 -68	-0.5%	-$4.48K	0.13%	81
2021 Q2	$941K	Buy	13,981 +43	+0.3%	+$2.8K	0.15%	75
2021 Q1	$870K	Sell	13,938 -12	-0.1%	-$747	0.15%	76
2020 Q4	$865K	Sell	13,950 -12	-0.1%	-$738	0.16%	73
2020 Q3	$835K	Buy	13,962 +10,151	+266%	+$611K	0.19%	57
2020 Q2	$226K	Buy	+3,811	New	+$228K	0.07%	136

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

INVST's BMY Position: Q2 2024 in Review

INVST sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 4,680 shares — an estimated $248K sold.

INVST first reported a position in BMY in Q2 2020 and held it in 16 quarters. The position peaked at $941K in Q2 2021. 2,154 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

INVST reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
INVST sold 4,680 Bristol-Myers Squibb shares in Q2 2024, an estimated $248K.
INVST first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 16 quarters.
INVST's Bristol-Myers Squibb position peaked at $941K in Q2 2021.
2,154 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on INVST's 13F filing for Q2 2024, filed 16 Aug 2024.